Curtis Lockshin is Chief Sciencific Officer of Xenetic Biosciences, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Phio Pharmaceuticals Corp.
12 Sep 24
4
Xenetic Biosciences, Inc.
13 Dec 23
4
Phio Pharmaceuticals Corp.
22 Feb 23
4
Xenetic Biosciences, Inc.
28 Mar 22
4
Phio Pharmaceuticals Corp.
16 Feb 22
4
Xenetic Biosciences, Inc.
22 Mar 21
4
Phio Pharmaceuticals Corp.
3 Mar 21
4
Xenetic Biosciences, Inc.
6 Dec 19
4
Phio Pharmaceuticals Corp.
15 Feb 19
4
RXi Pharmaceuticals Corp
3 Aug 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Sep 24 | PHIO Phio Pharmaceuticals | Common Stock, $0.0001 par value | Grant | Acquire A | No | No | 0 | 2,000 | 0.00 | 2,000 |
11 Dec 23 | XBIO Xenetic Biosciences | Stock Options Common Stock | Grant | Acquire A | No | No | 3.88 | 10,000 | 38.80 k | 10,000 |